Tissue inhibitor of metalloproteinases-3 mediates the death of immature oligodendrocytes via TNF-α/TACE in focal cerebral ischemia in mice by Yang, Yi et al.
RESEARCH Open Access
Tissue inhibitor of metalloproteinases-3 mediates
the death of immature oligodendrocytes via TNF-
a/TACE in focal cerebral ischemia in mice
Yi Yang
1, Fakhreya Y Jalal
1, Jeffrey F Thompson
1, Espen J Walker
5, Eduardo Candelario-Jalil
1,L uL i
2,
Ross R Reichard
4, Chi Ben
6, Qing-Xiang Sang
6, Lee Anna Cunningham
2 and Gary A Rosenberg
1,2,3*
Abstract
Background and Purpose: Oligodendrocyte (OL) death is important in focal cerebral ischemia. TIMP-3 promotes
apoptosis in ischemic neurons by inhibiting proteolysis of TNF-a superfamily of death receptors. Since OLs
undergo apoptosis during ischemia, we hypothesized that TIMP-3 contributes to OL death.
Methods: Middle cerebral artery occlusion (MCAO) was induced in Timp-3 knockout (KO) and wild type (WT) mice
with 24 or 72 h of reperfusion. Cell death in white matter was investigated by stereology and TUNEL. Mature or
immature OLs were identified using antibodies against glutathione S-transferase-π (GST-π) and galactocerebroside
(GalC), respectively. Expression and level of proteins were examined using immunohistochemistry and
immunoblotting. Protein activities were determined using a FRET peptide.
Results: Loss of OL-like cells was detected at 72 h only in WT ischemic white matter where TUNEL showed greater
cell death. TIMP-3 expression was increased in WT reactive astrocytes. GST-π was reduced in ischemic white matter
of WT mice compared with WT shams with no difference between KO and WT at 72 h. GalC level was significantly
increased in both KO and WT ischemic white matter at 72 h. However, the increase in GalC in KO mice was
significantly higher than WT; most TUNEL-positive cells in ischemic white matter expressed GalC, suggesting TIMP-3
deficiency protects the immature OLs from apoptosis. There were significantly higher levels of cleaved caspase-3 at
72 h in WT white matter than in KO. Greater expression of MMP-3 and -9 was seen in reactive astrocytes and/or
microglia/macrophages in WT at 72 h. We found more microglia/macrophages in WT than in KO, which were the
predominant source of increased TNF-a detected in the ischemic white matter. TACE activity was significantly
increased in ischemic WT white matter, which was expressed in active microglia/macrophages and OLs.
Conclusions: Our results suggested that focal ischemia leads to proliferation of immature OLs in white matter and that
TIMP-3 contributes to a caspase-3-dependent immature OL death via TNF-a-mediated neuroinflammation. Future
studies will be needed to delineate the role of MMP-3 and MMP-9 that were increased in the Timp-3 wild type.
Background
Oligodendrocytes (OLs) undergo a complex pattern of
death in cerebral ischemia with an early loss from gluta-
mate excitotoxicity and a slower death due to apoptosis
[1-4]. The vulnerability of OLs to ischemia was shown
morphologically [5] and the molecular mechanism was
related to excitotoxicity via the glutamate AMPA
receptors [6,7]. Ischemia results in apoptosis of OLs, but
the mechanisms involved are less well understood. The
pro-inflammatory factor tumor necrosis factor-a (TNF-
a) and TNF death receptors play an important role in
OL death as shown in vitro and in vivo [1,8,9]. Cerebral
ischemia results in an inflammatory response consisting
of microglia activation, gliosis, and cell death. Activated
microglia and reactive astrocytes produce TNF-a and
interleukin-1b (IL-1b), which are associated with peri-
ventricular white matter damage in hypoxic neonatal
brain [10]. Extravasation of inflammatory cells into the
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any medium, provided the original work is properly cited.central nervous system (CNS) is facilitated by extracellu-
lar activities of matrix metalloproteinases (MMPs) that
are regulated, in part, by the endogenous tissue inhibi-
tors of metalloproteinases (TIMPs) [11].
Cell surface sheddases, including TNF-a converting
enzyme (TACE) and stromelysin-1 (MMP-3) regulate
the TNF superfamily of death receptors by activating
the ligands and removing the death receptors from the
cell surface. Tissue inhibitor of metalloproteinases-3
(TIMP-3) plays a central role in this process by inhibit-
ing TACE and MMP-3. In an early study, TIMP-3
blocked the release of the TNF death receptor by
TACE, promoting apoptosis [12]. More recently, we
observed that TIMP-3 expression in ischemic neurons
was associated with APO-1 (Fas/CD95) and DNA frag-
mentation [13]. Using neuronal cell cultures, we have
demonstrated that TIMP-3 promoted apoptosis by pre-
venting the shedding of Fas receptors from the neuronal
cell surface during oxygen-glucose deprivation, and that
the Timp-3 knockout (KO) mouse showed reduced neu-
ronal death after a middle cerebral artery occlusion
(MCAO) with reperfusion compared to the wild type
(WT) [14,15].
Because of TIMP-3’s unique role as a cell surface inhi-
bitor of TACE and MMP-3, it could contribute to cell
death in OLs by promoting retention of TNF death
receptors [16]. To investigate the role of TIMP-3 in OL
cell loss, we induced a middle cerebral artery occlusion
(MCAO) in Timp-3 knockout (KO) and wild type (WT)
mice followed by 24 and 72 h of reperfusion. We
hypothesized that TIMP-3 and Fas/CD95 expression
occurred early in neurons and preceded DNA fragmen-
tation, but that in white matter TIMP-3 may contribute
t oO Ld e a t ht h a ti sa s s o c i a t e dw i t hT N F - a receptors.
We report that TIMP-3 deficiency protects the imma-
ture OLs from apoptotic death in white matter induced
by ischemia-reperfusion injury. The immature OL death
in the WT was associated with increased expression of
MMPs, TIMP-3, TNF-a/TACE in reactive astrocytes
and/or infiltrating macrophages/microglia in white
matter.
Methods
MCAO with reperfusion
The study was approved by the University of New Mex-
ico Animal Care Committee and conformed to the
National Institutes of Health Guide for the Care and
Use of Animals in research. Eighty-nine male Timp-3
KO (n = 44) and WT (n = 45) mice weighing 20-30 g
(age 10-12 weeks) were employed in this study. Fifty-
nine animals were subjected to 90 min MCAO using
t h ei n t r a l u m i n a lt h r e a dm e t h o df o l l o w e db y2 4o r7 2h
reperfusion. MCAO was performed as previously
described [15,17]. Mice underwent reperfusion via the
circle of Willis. Thirty sham-operated animals were
anesthetized and had a suture introduced into the com-
mon carotid artery and immediately removed.
Primary antibodies and dilutions used in
immunohistochemistry
Glial fibrillary acidic protein (GFAP) (1:400; Sigma), Iba-
1 (1:200; Wako Pure Chemical Industries), GST-π
(1:600, Abcam), GalC (1:300, Millipore), Fas (1:400;
Santa Cruz Biotechnology), Fas ligand (1:400; Santa
Cruz Biotechnology), MMP-2 (1:250; Chemicon), MMP-
3 (1:1500; Chemicon), MMP-9 (1:1000; Chemicon), cas-
pase-3 (1:1000, Cell Signaling), TIMP-3 (1:1000; Chemi-
con), TNF-a (15 μg/ml; R&D Systems), TNF Receptor I
(1:1000; Abcam), von Willebrand Factor (vWF) (10 μg/
ml; Chemicon), myeloperoxidase (MPO; 1:250; Santa
Cruz Biotechnology), and several markers for oligoden-
droglia; RIP (1:200,000;C h e m i c o n ) ,C N P a s e( 1 5μg/ml;
Chemicon), and CC-1 (APC; 10 μg/ml; Calbiochem).
Immunohistochemistry
Brain tissues fixed with 2% paraformaldehyde, 0.1 M
sodium periodate, 0.075 M lysine in 100 mM phosphate
buffer at pH 7.3 (PLP) were used for immunohistochem-
ical analysis. For immunofluorescence, 10 μm PLP-fixed
brain sections were treated with acetone and blocked
with 5% normal serum. Primary antibodies were incu-
bated for two nights at 4°C. Slides were incubated for 90
min at room temperature with secondary antibodies
conjugated with FITC or Cy-3 (Jackson). 4’-6-diami-
dino-2-phenylindole (DAPI; Molecular Probes) was used
to label cell nuclei.
For brightfield immunolabeling, 10 μm PLP-fixed sec-
tions were rehydrated through alcohol series and incu-
bated in phosphate buffered saline and 0.1% Tween-20
pH 7.3 (PBT) prior to blocking with 5% normal serum
in PBT. Slides were incubated with primary antibodies
for 48 h at 4°C followed by 1 h incubation with biotiny-
lated secondary antibodies, Vectastain Elite ABC
reagents (Vector Laboratories) and reacted with 3,3’-dia-
minobenzidine (DAB) was used for visualization of
immunolabeling. Cresyl violet acetate (CVA, Sigma-
Aldrich) was used for counterstaining.
Immunohistochemistry negative controls were incu-
bated without the primary antibody or with normal
(non-immune) IgGs and did not exhibit specific immu-
nolabelling. All immunohistochemically stained slides
were viewed on an Olympus BX-51 bright field and
fluorescence microscope (Olympus America Inc.)
equipped with an Optronics digital camera and Picture
Frame image capture software (Optronics). Dual immu-
nofluorescence slides were also imaged using high reso-
lution confocal microscopy to verify co-localization of
antigens (Zeiss LSM 510, Carl Zeiss Microimaging).
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ware (NIH software).
Stereological Counts
The cellular composition of the white matter is com-
prised of > 90% OLs [18] consisting of OL progenitors,
immature, and mature OLs. Antibodies used to identify
mature OLs, including CC-1, RIP, and CNPase, either
labeled too few OL cell bodies or obscured the cell
bodies in the processes. To measure white matter
damage in mouse focal ischemia, we first assessed loss
of OL-like cells in white matter [2] using multiple-anti-
body immunostaining [19]. Labeling cells with a Nissl
substance stain, such as cresyl violet acetate (CVA), all
cells are clearly observable and an assessment of OL
density can be determined stereologically. To distinguish
OLs from astrocytes and microglia, we stained slides
with GFAP for astrocytes and Iba-1 for microglia, using
the DAB method. All slides were counterstained with
CVA. By eliminating DAB-stained astrocytes and micro-
glia, small CVA-positive cell bodies that were negative
for GFAP and Iba-1 immunoreactivity were identified as
OL-like cells and quantified using unbiased stereology
with StereoInvestigator (Version 6, MBF Bioscience)
software controlling a motorized stage equipped Olym-
pus BX-51 microscope [19]. Employing the optical frac-
tionator function of StereoInvestigator, we estimated
OL-like cell number in the medial corpus callosum (CC)
and external capsule (EC) regions of white matter over a
total distance of 3.0 mm rostral and caudal to bregma.
Tissue sections were blinded to the investigator as to
animal identity and reperfusion time. A subset of slides
was stained with myeloperoxidase or von Willebrand
factor to identify neutrophils and endothelial cells.
These could be distinguished from the OL-like cells
based on morphology (data not shown).
Western blots
Western blot was performed to determine protein levels
in ischemic white matter. Proteins were extracted in
RIPA buffer from punch biopsies of white matter in
ischemic and nonischemic external capsule regions of
Timp-3 KO and WT mice. 50 μg total protein was sepa-
rated on 10% or 12% gels. The proteins were transferred
to polyvinylidene fluoride (PVDF) membranes. The
membranes were then incubated with primary antibo-
dies: MBP (1:2000, Millipore), GST-π (1:5000, Abcam),
GalC (1:500, Millipore), MMP-3 (1:1000, Epitomics),
both inactive (pro-) and active (cleaved) caspase-3
(1:1000; Cell Signaling Technology), and TNFR1
(1:1000; Abcam). The membranes were incubated with
the respective secondary antibodies and blots were
developed using the West Pico Detection System
(Pierce). Protein bands were visualized on X-ray film.
Semiquantitation of target protein intensities was done
with the use of Scion image software (Scion), and Brilli-
ant Blue R (Sigma-Aldrich) staining on the same PVDF
membranes was used to normalize protein loading and
transfer. The results are reported as normalized band
intensity for quantifying relative protein expression.
TUNEL assay
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) assay was done to identify
the extent of DNA fragmentation. Using the Neuro-
TACS II kit (Trevigen) brain sections were treated fol-
lowing the procedure specified by the manufacturer. For
dual immunofluorescence, the brain sections were then
exposed to the primary antibodies and streptavidin
fluorescein and Cy-3 secondary antibodies. For positive
controls the nuclease provided with the kit was added
to the labeling reaction mix and induced TUNEL posi-
tivity in all cells. As negative controls, slides were pre-
pared in a labeling reaction mix without the TdT
enzyme resulting in no TUNEL positivity (data not
shown).
Enzymatic assay of MMP-3 activity using a fluorescence
resonance energy transfer (FRET) peptide
MMP-3 enzymatic activity was assessed using a peptide-
based FRET assay. In the intact FRET peptide, Mca-
Arg-Pro-Lys-Pro-Val-Glu-Nva-Trp-Arg-Lys(Dnp)-NH2,
obtained from Bachem (Torrance, CA) the fluorescence
of Mca (7-methoxycoumarin-4-acetyl) is quenched by
Dnp (2,4-dinitrophenyl). Upon cleavage into two sepa-
rate fragments by the MMP-3 present in the sample, the
fluorescence of Mca was recovered, and monitored at
lex =3 2 8n ma n dlem= 393 nm using a spectrofluori-
meter (Perkin-Elmer LS 50B).
Brain tissue was homogenized in lysis buffer contain-
ing 50 mM Tris-HCl pH 7.6, 150 mM NaCl, 5 mM
CaCl2, 0.05% Brij-35, 0.02% NaN3,a n d1 %T r i t o nX -
100, and centrifuged at 12,000 × g for 5 min at 4°C.
Equal amount of total protein (6-10 μg) was mixed with
assay buffer containing 50 mM HEPES buffer pH 7.5,
200 mM NaCl, 10 mM CaCl2, 0.01% Brij-35, and fluoro-
genic substrate (1 μM final concentration) to a final
volume of 200 μl. Fluorescence was monitored for 15
min. The relationship between fluorescence units and
nM of product produced was determined from the
fluorescence values obtained when all the substrate was
hydrolyzed.
Fluorometric assay of TNF-a converting enzyme (TACE)
activity
TACE activity was measured using the fluorometric
SensoLyte 520 TACE (a-Secretase) Activity Assay Kit
(AnaSpec) according to the manufacturer’si n s t r u c t i o n s .
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FAM (fluorophore) and QXL™ 520 (quencher) labeled
FRET peptide substrate for continuous measurement of
enzyme activity. In the intact FRET peptide, the fluores-
cence of 5-FAM is quenched by QXL™ 520. Upon clea-
vage of the FRET peptide by the active enzyme, the
fluorescence of 5-FAM is recovered, and can be con-
tinuously monitored at lex = 490 nm/520 nm. TACE
activity was measured in theb r a i nt i s s u eh o m o g e n i z e d
as described before for MMP-3 activity. Equal amount
of total protein was mixed with assay buffer (AnaSpec)
and TACE substrate to a final volume of 100 μl. Fluor-
escence was monitored for 60 min with data recorded
every 5 min. Fluorescence was expressed as relative
fluorescence units (RFU). Some brain samples from KO
and WT mice had 10 μlo f1 0μM TACE inhibitor,
TAPI-0, added as a control.
Data analysis
Statistical comparisons among groups were done using
ANOVA with post-hoc analysis for multiple t-t e s t s
(Prism 4.0, GraphPad Software Inc.). All data are pre-
sented as mean ± standard error of the mean (S.E.M.).
Statistical significance was set at p < 0.05.
Results
Timp-3 KO mice were protected from delayed immature
OL death
Two regions of ischemic white matter were analyzed:
the corpus callosum (CC) and the external capsule (EC).
No OL-like cell loss was seen in ischemic CCs in both
K Oa n dW Tm i c ea t2 4a n d7 2h( d a t an o ts h o w n )o r
in ischemic EC at 24 h (Figure 1A, top two panels).
Representative regions from the nonischemic and the
ischemic EC at 72 h showed the normal appearing OL-
like cells in the nonischemic sides and the reactive
astrocytosis and/or microglia/macrophages in the
ischemic ECs in KO and WT (Figure 1A. bottom two
panels). The ischemic EC in KO showed no observable
loss of OL-like cells, while the ischemic EC in WT had
marked loss of OL-like cells (Figure 1A, bottom two
panels).
Next, the loss of OL-like cells in ischemic white mat-
ter was quantified by unbiased stereology. At 24 h, KO
and WT mice showed similar cell counts in the
ischemic and the nonischemic hemispheres (Figure 1B).
By 72 h, there was a significant loss of OL-like cells in
t h ei s c h e m i cE Co fW Tc o m p a r e dt oK Om i c e( p<
0.01). Furthermore, there was a significant loss of cells
in the ischemic compared to the nonischemic hemi-
sphere in WT only (p < 0.05). In the CC, no significant
reduction of OL-like cells was detected in either WT or
KO ischemic CC at 72 h (data not shown). Next, we
investigated apoptotic cell death in ischemic EC at 72 h
of reperfusion by TUNEL assay. More TUNEL-positive
cells were detected in ischemic WT hemisphere includ-
ing the EC region compared with KO (Figure 1C). The
difference in the distribution of TUNEL-positive cells
between the ischemic KO and WT hemispheres is con-
sistent with the patterns of the neuronal degeneration
revealed by Fluoro-Jade staining (Figure 1D). This result
suggested that ischemia-reperfusion injury induced a
delayed cell loss in white matter in which TIMP-3 may
be involved.
We then studied the expression of TIMP-3 in astro-
cytes and OLs in WT mice. At 24 h, very little TIMP-3
was seen in the white matter. We observed a new popu-
lation of GFAP-positive astrocytes closely surrounding
the core infarct areas at 72 h (data not shown), which
has been reported by others [20]. Maximal TIMP-3
expression occurred at 72 h in GFAP-positive astrocytes
in ischemic EC (Figure 2A). Most of the astrocytes were
co-labeled with TIMP-3 and co-localization of TIMP-3
with CC1, an OL marker, was also seen by 72 h (Figure
2B). This temporal and spatial relationship of TIMP-3
expression and the loss of OL-like cells in ischemic EC
indicated the involvement of TIMP-3 in the white mat-
ter damage in focal cerebral ischemia.
To further investigate the role of TIMP-3 in OL death,
we examined the expression of myelin basic protein
(MBP) and glutathione S-transferase π (GST-π,o rG S T -
pi) [21], markers of mature OL, in ischemic ECs of KO
and WT mice at 72 h using Western blot analysis (Fig-
ure 3A). Unexpectedly, we found no significant changes
of MBP level either in ischemic ECs between KO and
WT mice or between ischemic ECs and sham ECs.
However, we observed a significant decrease of GST-π
level in WT ischemic EC compared with sham WT
mice. Next, we tested the expression of galactocerebro-
side (GalC), a marker of immature OL [22,23]. We
found that a significant increase in GalC was seen in
ischemic ECs of WT and KO by 72 h reperfusion after
ischemia compared with sham WT (p < 0.001) and
sham KO (p < 0.05), respectively. Most importantly,
TIMP-3 KO mouse shows significantly higher levels of
GalC expression in white matter than WT mouse (p <
0.01). These findings suggested that TIMP-3-mediated
delayed OL death mainly occurs in immature OLs in
white matter after ischemic stroke with reperfusion
injury.
To confirm the observation that TIMP-3 contributed
to delayed immature OL death in ischemic white matter,
we next performed immunohistochemistry of GST-π
and GalC on brain tissue from KO and WT mice with
90 min-MCAO and 72 h reperfusion (Figure 3B). Dou-
ble-immunostaining of GST-π and GalC demonstrated
stronger immunohistochemical signals of GST-π and
GalC in ischemic KO EC than WT EC. Furthermore, we
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Page 4 of 14Figure 1 White matter injury and OL-like cell loss in EC at 72 h in Timp-3 KO and WT mice. A. Representative regions from the
nonischemic and the ischemic EC at 24 and 72 h. Iba-1 (microglia/macrophage) and GFAP (astrocyte) were both stained with DAB and
counterstained with cresyl violet acetate (CVA). The intact linear rows of dark-staining nuclei by CVA were formed by OL-like cells (arrows) in
nonischemic ECs at 24 and 72 h, as well as in ischemic ECs at 24 h. Ischemic EC shows massive DAB-positive glial cells at 72 h. A marked loss of
CVA positive cells was seen in ischemic EC in WT mouse compared with that in KO mouse. Scale bars = 50 μm. B. Stereological counting of OL-
like cells in ischemic EC at 24 and 72 h reperfusion shows OL-like counts were similar at 24 h between Timp-3 KO and WT ischemic. A significant
loss of OL-like cells occurred at 72 h in the WT ischemic EC compared to KO ischemic and to the WT nonischemic EC (p < 0.01 and 0.05,
respectively, n = 6). From 24 to 72 h, OLs in ischemic KO EC remained unchanged. The brain cartoon shows location of regions used for OL
counting (shaded areas). CC: corpus callosum; EC: external capsule. Micrographic image shows Iba-1 and GFAP (arrows) visualized by DAB in
higher magnification. C. TUNEL assay demonstrates apoptotic cell death in ischemic EC at 72 h reperfusion. TUNEL-positive cells were seen in
ischemic WT EC. Scale bar = 100 μm. D. Distribution of neuronal degeneration in ischemic hemispheres in Timp-3 KO and WT mice at 24 and 72
h of reperfusion following 90 min transient MCAO. Coronal sections were stained for degenerating neurons using Fluoro-Jade (FluoJ). Number of
FluoJ-positive cells was much greater in WT than in KO at both tiom points. La-ctx: lateral cortex, stri: striatum, pcf: piriform cortex. Scale bar =
100 μm.
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We found TUNEL-positive cells in ischemic EC at 72 h,
which mostly co-localized with GalC-positive OLs (Fig-
ure 3C).
Caspase-3 increased in WT compared to Timp-3 KO
To study the possible mechanism of TIMP-3-mediated
cell death, we used immunohistochemistry to determine
the expression of caspase-3, since apoptosis has been
implied in immature and mature OL death [1,10,24-26].
In the ischemic EC of the WT, greater caspase-3
immunoreactivity was detected at 24 h of reperfusion
than in the KO. There was loss of DAPI stained nuclei
(blue) in the WT EC as compared with the KO EC at
72 h reperfusion (Figure 4A).
Western blots were done with an antibody that recog-
nizes both pro- and cleaved-caspase-3. The activated
caspase-3 often appears as multiple cleaved bands
migrating variably in the 17-20 kDa range [27]. There
was no detectable cleaved (active) caspase-3 (17/19 kDa)
in white matter of KO and WT mice at 24 h after
stroke. Western blots exhibited strong immunoreactive
Figure 2 TIMP-3 expression in astrocytes and OLs in ischemic EC at 72 h in Timp-3 WT mice. A. Photomicrographs show double
immunofluorescent-labeling of TIMP-3 and GFAP in sham-operated and ischemic EC at 24 and 72 h of reperfusion. TIMP-3 was not expressed in
GFAP-labeled astrocytes at 24 h, but by 72 h TIMP-3 was markedly expressed and co-localized with astrocytes (arrows). The co-localization of
TIMP-3 and GFAP was confirmed by Z-stack confocal image. B. CC1-positive OLs express TIMP-3 (arrows) in ischemic EC at 72 h. The co-
localization of TIMP-3 and CC1 was confirmed by Z-stack confocal image. Scale bars = 50 μm.
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caspase-3 (Figure 4B). A significant increase of pro-cas-
pase-3 was demonstrated in ischemic white matter of
WT mice (p < 0.05), indicating that caspase-3 was
markedly induced in WT mice at 24 h reperfusion after
stroke. By 72 h there were no differences in pro-cas-
pase-3 expression in the white matter of KO or WT
mice (Figure 4C). More importantly, a statistically
increased level of cleaved caspase-3 (17/19 kDa) was
seen in ischemic WT white matter (p < 0.05), implicat-
ing an apoptotic mechanism in OL loss (Figure 4C).
MMP-3 and -9 increased in WT compared to Timp-3 KO
Since TIMP-3 regulates the activities of MMPs that are
important in processes involved in growth, cell death,
and tissue repair [28], we next investigated the expres-
sion of MMP-2, -3 and -9 in the ischemic white matter
of Timp-3 KO and WT utilizing immunohistochemistry
(Figure 5A). Co-labeling of the MMPs and GFAP
showed more MMP-2 immunoreactivity in the KO
white matter than in the WT at 72 h. Increased expres-
sion of MMP-2 in Timp-3 KO mice had been observed
previously in other disease models and attributed to
chronic damage in heart and lung [29,30]. The increased
MMP-2 expression was seen in GFAP-positive cells and
around blood vessels. On the other hand, WT mice had
more immunostaining for MMP-3 and -9 in EC than
s e e ni nt h eK Oa t7 2h .M M P - 3a n d - 9w e r es e e ni n
astrocytes around blood vessels (Figure 5A), while
MMP-3 was also seen in OL cells and microglia/
Figure 3 Immature and mature OL loss in Timp-3 WT mice at 72 h. A. Western blots for MBP, GST-pi (π) and GalC in white matter in
reperfusion injury at 72 h in WT and KO mice. No significant changes of MBP level were detected at 72 h reperfusion after ischemia in both WT
and KO mice. Significantly decreased levels of GST-π was seen in ischemic WT compared with sham WT (SWT) (p < 0.01, n = 5 for each group).
Significant increase of GalC was seen in ischemic WT and KO compared with sham WT (p < 0.001, n = 5 for each group) and sham KO (SKO) (p
< 0.05), respectively. Timp-3 KO mouse shows significantly higher levels of GalC in white matter than WT mouse (p < 0.01). Intensity of total
proteins stained by Brilliant blue R on the same blots was performed as control for protein loading and transfer normalization. The results were
presented as ratio of protein expression between ischemic and nonischemic white matter. B. Double-immunostaining of GST-π (red) and GalC
(green), showing the expression of mature and immature OLs in ischemic external capsule at 72 h reperfusion in Timp-3 KO and WT mice. More
GST-π- and GalC-positive signals were seen in KO ischemic EC than in WT. Inserts show immunohistochemistry of GST-π and GalC in sham-
operated animals. C. Co-localizarion of TUNEL labeling GST-π or GalC immunohistochemistry in ischemic WT EC at 72 h reperfusion. Arrows show
the co-localization of TUNEL-positive cells with GST-π or GalC expression was seen in ischemic EC (insert 1 and 2). Scale bars = 50 μm.
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very few astrocytes were detected (Figure 5A, B and 5C).
The observation of higher expression of MMP-3 in glial
cells in WT white matter was unexpected since TIMP-3
is supposed to inhibit MMP-3 on the cell surface [28].
We quantified the MMP-3 protein in white matter by
Western blot and measured its activity with a fluorogenic
activity assay. We found increased MMP-3 (both pro-
and active forms) in the ischemic hemisphere of the WT
compared to the KO (Figure 5D). The fluorogenic assay
showed a statistically significant increase in the activation
of MMP-3 in the WT only (Figure 5E).
Increased microglia/macrophage expressing TNF-a and
TACE activity in WT compared to Timp-3 KO
Death of OLs can occur through death receptors of the
TNF superfamily, including Fas/FasL and TNF-a/TNFR.
Double immunostaining with Fas and FasL antibodies
demonstrated greater Fas/FasL signal in the gray matter
of KO mice at 24 h (Figure 6). Considering the neuronal
Figure 4 Caspase-3 expression in ischemic EC in Timp-3 KO and WT mice at 24 and 72 h. A. Immunostaining shows that expression of
caspase-3 was detected in ischemic WT EC 24 h after reperfusion. The increased caspase-3 expression in WT was present in OL-like cells. Less
caspase-3 immunostaining was detected in both ischemic WT and KO ECs at 72 h, while nuclear counterstaining with DAPI (blue) showed
greater loss of cells in ischemic WT EC. Insert 1 and 2 show caspase-3 immunostaing is associated with nuclei (arrows). Scale bars = 50 μm. B.
Western blots for expression of caspase-3 in white matter at 24 h in Timp-3 KO and WT mice. The graph shows an increase in pro-caspase-3
band at 32 kDa in the ischemic EC of the WT mice (p < 0.05, n = 4). Cleaved caspase-3 (17 kDa and 19 kDa) was not detected. Brilliant blue R
staining on the same blots was performed as control for protein loading and transfer. C. Western blots for caspase-3 in white matter in
reperfusion injury at 72 h showed no difference in expression of pro-caspase-3 between WT and KO, but increased cleaved caspase-3 (19 kDa
and 17 kDa) in ischemic WT white matter (p < 0.05, n = 6 for each group).
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than KO (Figure 1D), the greater Fas/FasL signal in gray
matter in KO mice at 24 h suggests delayed cell death
compared with WT mice. However, Fas/FasL signal was
not detected in white matter in KO or WT mice at both
24 and 72 h reperfusion after focal ischemia (Figure 6).
Since TNF-a and activated microglia and macrophages
are associated with white matter damage, we then
investigated the TNF-a expression in microglia/macro-
phages. TNF-a was increased in white matter of Timp-3
WT mice after 72 h reperfusion, and it was co-localized
with Iba-1-positive microglia/macrophages (Figure 7A and
7B). Furthermore, we observed greater Iba-1-positive
microglia/macrophages that expressed TNF-a in WT
white matter at 72 h. For quantification of Iba-1, we evalu-
ated fields of the ischemic EC as well as cortical and
Figure 5 Expression of MMPs in ischemic EC in Timp-3 KO and WT mice at 72 h. A. Immunohistochemistry for MMPs in ischemic external
capsule (EC) at 72 h reperfusion in Timp-3 KO and WT mice. The Timp-3 knockout had increased MMP-2 (red) immunoreactivity in ischemia,
which co-localized with GFAP-expressing astrocytes (yellow). MMP-9 and MMP-3 were co-localized with astrocytes in the WT. Arrowheads show
MMP-9 and -3 in astrocytes around vessels. Insert shows co-localization of MMP-3 and GFAP-positive astrocyte. Scale bar = 100 μm. B.
Immunostaining shows MMP-3 expression in CC1-positive OLs in ischemic WT EC. C. Immunostaining shows MMP-3 expression in Iba-1 positive
microglia/macrophages. Scale bar = 50 μm. D. Western blot of MMP-3 at 72 h reperfusion in Timp-3 KO and WT mouse brains. Western blots of
MMP-3 standard and mouse brain tissues show the proform of MMP-3 at 57 kDa and an active form at 45 kDa. A 60 kDa glycosylated form of
MMP-3 is also present in all brain samples. Brilliant blue R staining on the same blots was performed as control for protein loading and transfer.
Quantification of pro and active MMP-3 forms together showed a significant increase in MMP-3 (57 kDa and 45 kDa) in ischemic WT compared
with ischemic KO, sham KO and WT and nonischemic KO and WT (p < 0.05, n = 6 for each group). No significant difference was found between
ischemic and nonischemic hemispheres in the KO. E. Fluorogenic substrate assay for MMP-3 activity shows significant increase in MMP-3 relative
activity in both ischemic and nonischemic WT compared with sham WT (p < 0.05, n = 6 for each group).
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Page 9 of 14striatal tissue immediately bordering the EC in each sec-
tion, quantifying the amount of fluorescent intensity of
Iba-1 as assessed in five brains per group at each time
point. We found significantly greater fluorescence of Iba-1
in ischemic WT EC compared to KO at both 24 and 72 h
after ischemia (Figure 7C). These results suggest that
TIMP-3 facilitates the inflammatory response to ischemia-
reperfusion injury.
Since TIMP-3 inhibits TACE, which both generates
soluble TNF-a (17 kDa) from the 21 kDa cell surface form
and cleaves the TNF receptors, we measured TACE activ-
ity in white matter from Timp-3 KO and WT mice at 72 h
reperfusion. Ischemia with 72 h reperfusion resulted in a
significant increase in activation of TACE in white matter
of WT mouse compared with KO (Figure 7D). The double
staining of TACE and Iba-1 or CC1 showed the expression
of TACE in Iba-1-positive microglia/macrophages and
OLs in WT white matter (Figure 7E).
The excess presence of TNF-a in white matter could
trigger cell apoptosis by ligation with the TNFR-1. We
determined the presence of this receptor and the cell
type expressing it by immunohistochemistry. We found
that the TNFR-1 co-localized with the OL marker, CC1
(Figure 7F). Western blot showed no difference of TNFR-
1 expression between KO and WT mice (Figure 7F).
Discussion
W ef o u n dt h a td e l e t i o no ft h eTimp-3 gene reduced
immature OL death at 72 h following MCAO-induced
focal ischemia with reperfusion. TUNEL assay demon-
strated apoptotic death of immature OLs. There was an
increase in pro-caspase-3 at 24 h and cleaved caspase-3
at 72 h in white matter, indicating apoptosis was
occurring at the time of delayed immature OL death.
The presence of Timp-3 in the wild type led to an exag-
gerated inflammatory response with an increase in both
infiltration of microglia/macrophages at 72 h and
expression of MMP-3 and -9 in reactive astrocytes
around blood vessels in the white matter. We found
increased activity of TACE and TNF-a in microglia/
macrophages, while TNFR-1 was expressed on OLs.
Finally, WT mice had an increase in active microglia/
macrophages compared with KO mice. These results
provide the first evidence for TIMP-3 induction of
inflammation and promotion of delayed immature OL
death via a TNF-a-mediated mechanism.
An unexpected finding in this study was that TIMP-3
mainly promoted immature OL rather than mature OL
death. Glutathione S-transferase π (GST-π) is a cytosolic
isoenzyme in mature OLs, which is a marker of mature
OLs in mammalian brain [21,31-33]. Western blot and
immunohistochemistry showed a significant decrease in
GST-π protein in the ischemic EC of Timp-3 WT mice.
Although less GST-π protein disruption was seen in the
KO, MBP expression was similar in WT and KO mice.
We found preferential damage in immature OLs, which
has been reported in perinatal hypoxia-ischemia [4]. Oli-
godendrocyte-specific galactosphingolipid (GalC) is
expressed during differentiation of OL lineage cells,
including OL progenitor cells (OPCs), premyelinating
and myelinating OLs [34]. We used GalC as a marker
for immature OLs [35]. Our data demonstrated a signifi-
cant increase in GalC expression in ischemic EC in both
KO and WT mice. We found that immature OLs
undergo TIMP-3-mediated apoptosis associated with
TIMP-3 expression in reactive astrocytes. These findings
are consistent with the previous observation that OL
progenitors are more susceptible to death due to
hypoxia-ischemia than mature OLs in neonatal mice
[25].
Cell surface receptors and ligands of the TNF-a
superfamily play a fundamental role in apoptosis during
neuroinflammation and overproduction of the proin-
flammatory cytokine, TNF-a, has been implicated in the
pathogenesis of white matter damage [10,36]. TNF-a
decreases the number of OL progenitors by causing
their apoptosis [10,26,37]. Activated microglia and reac-
tive astrocytes release TNF-a and other cytokines [38].
We observed an increased infiltration of TNF-a-a n d
TACE-expressing microglia/macrophages in ischemic
white matter of WT mouse at 72 h. Timp-3 KO mouse
had reduced TNF-a expression and TACE activity and
showed fewer microglia/macrophages in ischemic white
matter, which is consistent with TIMP-3’sr o l ei n
enhancing inflammation in other tissues [39].
Co-labeling of MMPs and GFAP indicated astrocytes
showed more MMP-2 immunoreactivity in the KO
Figure 6 A. Immunohistochemistry for Fas and FasL in
ischemic EC at 24 and 72 h in Timp-3 KO and WT mouse
brains. No positive signal of Fas (green) and FasL (red) was
detected in both KO and WT ECs. Scale bars = 50 μm.
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Page 10 of 14white matter than WT, which is consistent with earlier
studies showing that Timp-3 KO mice have greater
MMP-2 activation during physiological and pathological
events [29,30]. On the contrary, WT mice showed more
immunostaining for MMP-3 and MMP-9 in ischemic
white matter than KO, and in reactive astrocytes around
vessels. MMPs disrupt the blood-brain barrier by cleav-
ing tight junction proteins at an early stage after ische-
mia-reperfusion injury in the rat [40]. MMP-3 can
proteolytically activate MMP-9 [41]. Therefore,
increased MMP-3 and -9 in astrocytes in white matter
may play a role in BBB damage with facilitation of infil-
tration of macrophages in WT mouse. In addition, we
also found increased active MMP-3 in OL-like cells and
microglia/macrophages. MMP-3 is associated with the
neuroinflammatory response. MMP-3 was shown to
activate microglia and increase the neuroinflammatory
response with expression of cytokines such as TNF-a
[42]. In dopaminergic neurons MMP-3 may have an
intracellular role in cell death [43,44]. We found
increased MMP-3 (both pro- and active forms) in the
ischemic hemisphere of the WT compared to the KO. A
f l u o r o g e n i ca s s a ys h o w e das i g n i f i c a n ti n c r e a s ei nt h e
activity of MMP-3 in the WT only. Although some stu-
dies suggest that MMP-3 contributes to cell death,
MMP-3 was protective to neurons in culture exposed to
doxorubicin through its role in cleaving the death recep-
tors and ligands [15]. Studies with the Mmp-3 knockout
mouse will be needed to resolve this issue.
OLs have cell surface receptors for members of the
TNF-a death receptor family, including TNFR-1, TNFR-
2, and Fas/CD95 [45]. TNF-R1 has an intracellular
Figure 7 Expression of TNF-a and TACE in ischemic EC in Timp-3 KO and WT mice at 72 h. A. Double-staining of TNF-a (red) and Iba-1
(green), showing the expression of TNF-a in microglia/macrophages (Iba-1 positive cells) in ischemic EC at 72 h reperfusion in Timp-3 KO and
WT mice. More TNF-a- and Iba-1-positive cells were seen in WT ischemic EC (arrows) than in KO. Scale bar = 40 μm. B. The three-dimension (3D)
and Z-stack confocal images shows the co-localization of TNF-a in macrophage. Scale bar = 5 μm. C. Quantification of Iba-1 fluorescent intensity
showed greater Iba-1-positive macrophages/microglia in Timp-3 WT mice compared with KO at both 24 and 72 h (p < 0.05, n = 5 for each
group). D. TACE activity measured by a fluorometric assay in ischemic white matter at 72 h reperfusion in Timp-3 KO and WT mouse brains.
Significant increase in TACE relative activity was seen in ischemic WT compared with ischemic KO (p < 0.05, n = 6) and sham WT (SWT) and KO
(SKO) (p < 0.01). A greater level of TACE activity was seen in nonischemic WT compared with contralateral sham WT (p < 0.05). E. Top panel: Co-
localization of TACE and Iba-1 in microglia/macrophages (arrows). Bottom: TACE and CC1 co-localization in OLs (arrows). Scale bars = 50 μm. F.
Z-stack confocal images show TNFR-1 co-localized in CC1-positive OLs. Western blot analysis shows no significant changes ether between
ischemic and nonischemic hemispheres or between KO and WT mice (n = 6).
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Page 11 of 14death domain and its activation leads to cell apoptosis
[46]. Aberrant TNF-a/TNF-R1 signaling can have a
potentially major role in the CNS pathologies in which
OL apoptosis and demyelination are primary pathologi-
cal features [47]. TNF-a is toxic to OLs in culture and
in periventricular white matter of hypoxic rats [26,48].
TIMP-3 inhibits the action of TACE, which both acti-
vates TNF-a to the mature 17-kDa form and releases
TNF death receptors from the cell surface [39]. Because
TIMP-3 interacts with a number of cell surface pro-
cesses, including formation of TNF-a by TACE, release
of TNFR-1 from the cell surface, and other events,
promoting either cell death or remodeling, the effect of
TIMP-3 is difficult to predict [39].
It should be noted that the MCAO produces damage
to the striatum, cortex, and the adjacent white matter.
This could result in some of the molecules produced by
the injury of the striatum/cortex influencing the damage
in the white matter. Other mechanisms of cell death are
possible in OLs where studies have shown that gluta-
mate induces OL cell death both through an action on
the cell body and on the ion channels of the axon
[6,49,50]. While the action of TIMP-3 in OL death
remains to be fully elucidated, it is possible to construct
Figure 8 Schematic drawing of hypothesis how TIMP-3 facilitates immature OL death after transient focal cerebral ischemia in mouse.
Route 1: TIMP-3 could block the shedding of various members of the death receptor families, including TNFR-1, by inhibiting TACE, stabilizing
the death receptor on the surface of OLs. Route 2: Later (3 days reperfusion; RP), TIMP-3 enhances the inflammatory response and the release of
inflammatory mediators in glial cells including TNF-a and MMP-3, which promote the OL death through a TNF-a-mediated mechanism.
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ment in the OL death that involves the activation of
microglia/macrophages by TIMP-3, which also inhibits
shedding of TNFR-1 by TACE. Figure 8 shows a
hypothetical mechanism for TIMP-3-facilitated death of
immature OLs in transient cerebral focal ischemia in
mice.
In conclusion, our results show that TIMP-3 contri-
butes to immature OL death in ischemic white matter
by increasing TACE, TNF-a, cleaved caspase- 3, and
activated MMP-3 and -9. We observed a cellular prefer-
ence with TIMP-3 strongly expressed in GFAP-positive
astrocytes, while TNF-a, TACE and MMP-3 appear in
microglia/macrophages and TNFR-1 is found in OLs.
T h e s er e s u l t sa r et h ef i r s tt oi m p l i c a t eT I M P - 3i nt h e
death of immature OLs by apoptosis and they suggest
that an interaction occurs between astrocytes expressing
TIMP-3, microglia/macrophages expressing TNF-a and
MMP-3, and OLs expressing TNFR-1 that facilitates the
death process. These results may have implications for
the delayed death of vulnerable OLs seen in a number
of hypoxic/ischemic neurological conditions.
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